In an era of volatile markets, investors are increasingly seeking stable, predictable income streams. Capital Prudential is ...
Neuren Pharmaceuticals (ASX:NEU) is focused on neurodevelopmental disorders and rare disease drug development.
INOVIQ (ASX:IIQ) is developing and commercialising next-generation diagnostics and therapeutics focused on exosome-based ...
Island Pharmaceuticals (ASX: ILA) announced it has successfully raised $2.72 million through the exercise of listed options ...
North Stawell Minerals has announced the intersection of visible gold at its Darlington Project in Victoria, located within ...
Trigg Minerals (ASX: TMG) has announced a binding agreement to acquire 100% rights to the Nundle, Upper Hunter, and ...
RocketBoots Limited announced the successful completion of a major customer trial of its loss prevention software across ...
Google has signed a definitive agreement to acquire Wiz, a New York-based cloud security startup, for $32 billion in an ...
Cyclopharm Limited (CYC) is experiencing a period of significant growth, primarily driven by its Technegas technology. The ...
Tesla’s stock dropped 5.34% on Tuesday, falling to $225.31, as concerns about increasing competition from China’s BYD, ...
Short sellers have made $16.2 billion (A$25.5 billion) in profits over the past three months as Tesla’s share price has plummeted by more than 50%. Since 17 December 2024, the company’s market value ...
The Trim Capital Group is an independent Australian advisory and asset management firm specialising in corporate advisory, equities, and private lending.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results